Callbox Builds US Pipeline for a Canadian Life Sciences CDMO
Client
- Medical and Healthcare
- Canada
- HQ: Canada
Target Market
- United States
- Biotechnology, Pharmaceutical, Specialty Pharma, Medical Devices and Diagnostics, Cell and Gene Therapy, Rare Disease Drug Development
- VP of Business Development, Heads of CMC (Chemistry, Manufacturing, and Controls), VP of Manufacturing, R&D Directors, Heads of Drug Substance and Drug Product Development, Chief Scientific Officers (CSOs), VP of Regulatory Affairs, Outsourcing and Procurement Directors
The Client
The Client is a Canadian-headquartered global life sciences CDMO with more than 150 years of pharmaceutical manufacturing experience, offering integrated drug substance and drug product development and manufacturing services from preclinical through commercial scale. With a global network of production sites across the US, Asia, and Australia, the Client delivers API synthesis, custom synthesis, oral solid dosage forms, sterile injectables, ophthalmics, inhalation products, and viral vector manufacturing, serving small, mid-size, and large pharmaceutical and biotech companies worldwide.
The Challenge
The Client had built a globally respected CDMO with proven capability across the full pharmaceutical development and manufacturing lifecycle, but despite deep Canadian and Asia Pacific credentials, the Client had limited traction in the highly competitive US pharmaceutical outsourcing market. With no dedicated US-facing outbound engine and no structured process for reaching the right decision-makers at the right stage of their outsourcing cycle, North America’s vast concentration of clinical-stage biotechs and pharmaceutical companies remained largely untapped.
Read the full case study
Fill in your details to unlock the complete campaign breakdown, strategy, and results for Medical and Healthcare.
What's Next?
Ready to see results like these?
Let our team build a tailored B2B lead generation campaign for your business.